Trichloroethylene accelerates an autoimmune response by Th₁ T cell activation in MRL +/+ miceGRIFFIN, J. M; BLOSSOM, S. J; JACKSON, S. K et al.Immunopharmacology (New York). 2000, Vol 46, Num 2, pp 123-137, issn 0162-3109Article

Applications of tacrolimus for the treatment of skin disordersASSMANN, T; HOMEY, B; RUZICKA, T et al.Immunopharmacology (New York). 2000, Vol 47, Num 2-3, pp 203-213, issn 0162-3109Article

The use of leflunomide in the treatment of rheumatoid arthritis : an experimental and clinical reviewSCHATTENKIRCHNER, M.Immunopharmacology (New York). 2000, Vol 47, Num 2-3, pp 291-298, issn 0162-3109Article

Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complementPANGBURN, M. K.Immunopharmacology (New York). 2000, Vol 49, Num 1-2, pp 149-157, issn 0162-3109Conference Paper

C1q : structure, function, and receptorsKISHORE, U; REID, K. B. M.Immunopharmacology (New York). 2000, Vol 49, Num 1-2, pp 159-170, issn 0162-3109Conference Paper

Genetic analysis of the Bordetella infectious cycleCOTTER, Peggy A; MILLER, Jeff F.Immunopharmacology (New York). 2000, Vol 48, Num 3, pp 253-255, issn 0162-3109Conference Paper

Nitric oxide, peroxynitrite, and lower respiratory tract inflammationROBBINS, Richard A; HADELI, Khaled; NELSON, Dan et al.Immunopharmacology (New York). 2000, Vol 48, Num 3, pp 217-221, issn 0162-3109Conference Paper

Angiotensin converting-like enzymes from urine of untreated renovascular hypertensive and normal patients : purification and characterizationCOSTA, R. H; CASARINI, D. E; PLAVNIK, F. L et al.Immunopharmacology (New York). 2000, Vol 46, Num 3, pp 237-246, issn 0162-3109Article

Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophagesMARCINKIEWICZ, Janusz; GRABOWSKA, Agnieszka; LAUTERBACH, Ryszard et al.Immunopharmacology (New York). 2000, Vol 49, Num 3, pp 335-343, issn 0162-3109Article

Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel immunosuppressantAZUMA, T; WATANABE, N; YAGISAWA, H et al.Immunopharmacology (New York). 2000, Vol 46, Num 1, pp 29-37, issn 0162-3109Article

Interleukin 2 maintains biologic stability and sterility over prolonged timeSAFAR, M; JUNGHANS, R. P.Immunopharmacology (New York). 2000, Vol 49, Num 3, pp 419-423, issn 0162-3109Article

Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4 + cells in their blood = Thalidomide is used for treating erythema nodosum leprosum. it is also used to treat aphthous ulcers in hiv-infected patients. the mechanism of action of this drug is yet to be fully understood, but modulation of inflammatory cytokines like il-2 and tnf-α may play a role. we investigated the effect of thalidomide on the production of il-2 and tnf-α by staphylococcal enterotoxin a (sea) stimulated peripheral blood mononuclear cells (pbmc) from hiv-infected patients. the pbmc from 20 patients was incubated in the presence of 4.0 μg/ml of thalidomide and 50 ng/ml of sea. after 18 h, the culture sSHANNON, E; ASEFFA, A; PANKEY, G et al.Immunopharmacology (New York). 2000, Vol 46, Num 2, pp 175-179, issn 0162-3109Article

Mixed effects of TGF-β on human airway epithelial-cell chemokine responsesJAGELS, M. A; HUGLI, T. E.Immunopharmacology (New York). 2000, Vol 48, Num 1, pp 17-26, issn 0162-3109Article

Orally administered decoction of Kampo (Japanese herbal) medicine, Juzen-Taiho-To modulates cytokine secretion and induces NKT cells in mouse liverMATSUMOTO, T; SAKURAI, M. H; KIYOHARA, H et al.Immunopharmacology (New York). 2000, Vol 46, Num 2, pp 149-161, issn 0162-3109Article

Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase CBARROCAS, A. M; COCHRANE, D. E; CARRAWAY, R. E et al.Immunopharmacology (New York). 1999, Vol 41, Num 2, pp 131-137, issn 0162-3109Article

Increased adsorption of high molecular weight kininogen to heparin-coated artificial surfaces and correlation to hemocompatibilityWENDEL, H. P; WEBER, N; ZIEMER, G et al.Immunopharmacology (New York). 1999, Vol 43, Num 2-3, pp 149-153, issn 0162-3109Conference Paper

Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Aβ protein of Alzheimer's diseaseJOSEPH, K; SHIBAYAMA, Y; NAKAZAWA, Y et al.Immunopharmacology (New York). 1999, Vol 43, Num 2-3, pp 203-210, issn 0162-3109Conference Paper

Correlation of kinin generating activity with Helicobacter pylori-associated gastric infectionNAIDOO, S; RAMSAROOP, R; BHOOLA, R et al.Immunopharmacology (New York). 1999, Vol 43, Num 2-3, pp 225-233, issn 0162-3109Conference Paper

Kinin receptors are expressed in human astrocytic tumour cellsRAIDOO, D. M; SAWANT, S; MAHABEER, R et al.Immunopharmacology (New York). 1999, Vol 43, Num 2-3, pp 255-263, issn 0162-3109Conference Paper

Bradykinin-potentiating peptides and C-type natriuretic peptides from snake venomHIGUCHI, S; MURAYAMA, N; SAGUCHI, K et al.Immunopharmacology (New York). 1999, Vol 44, Num 1-2, pp 129-135, issn 0162-3109Conference Paper

Potential mechanism for bradykinin-activated and inositol tetrakisphosphate-dependent Ca²⁺ influx by Ras and GAP1 in fibroblast cellsHIGASHIDA, H; TAKETO, M; TAKAHASHI, H et al.Immunopharmacology (New York). 1999, Vol 45, Num 1-3, pp 7-11, issn 0162-3109Conference Paper

Localization of B₂ bradykinin receptor mRNA in the rat retina and sclerocorneaTAKEDA, H; KIMURA, Y; HIGASHIDA, H et al.Immunopharmacology (New York). 1999, Vol 45, Num 1-3, pp 51-55, issn 0162-3109Conference Paper

Angioedema due to angiotensin-converting enzyme inhibitorsAGOSTONI, A; CICARDI, M; CUGNO, M et al.Immunopharmacology (New York). 1999, Vol 44, Num 1-2, pp 21-25, issn 0162-3109Conference Paper

LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish proteinFUJITA, H; YOSHIKAWA, M.Immunopharmacology (New York). 1999, Vol 44, Num 1-2, pp 123-127, issn 0162-3109Conference Paper

Effect of bradykinin on tyrosine kinase and phosphatase activities and cell proliferation in mesangial cellsALRIC, C; PECHER, C; BASCANDS, J.-L et al.Immunopharmacology (New York). 1999, Vol 45, Num 1-3, pp 57-62, issn 0162-3109Conference Paper